Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyFastRx vs Ryze Rx

MyFastRx
Graded #161

Higher grade

vs+9.399999999999991
Ryze Rx
Graded #376

Lower grade

The verdict

MyFastRx takes it — 67.6/100 to 58.2/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +32
76
44
Dose & formulationMyFastRx +8
72
64
Clinical oversightRyze Rx +9
66
75
Labs & monitoringEven
52
52
FulfillmentMyFastRx +14
83
69
Contract termsEven
41
41
MyFastRx · left barRyze Rx · right bar

The numbers

MetricMyFastRxRyze Rx
WeighScore67.6/10058.2/100
GradeCC
Scorecard rank#161#376
Semaglutide$169/mo$199/mo (starting dose, 3 month plan, compounded)
Tirzepatide$249/mo$199/mo (starting dose, 3 month plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
MyFastRx

Graded #161 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)
Ryze Rx

Graded #376 · C

Strengths

  • Compounded semaglutide and tirzepatide both $199/mo, with $499/$799 three-month bundles
  • Physician consultation, ongoing clinical support and discreet shipping included with each prescription
  • Broad catalog beyond GLP-1: TRT plus peptides (BPC-157, sermorelin, NAD+, retatrutide and more)
  • Free shipping, 24hr prescription turnaround, FSA/HSA eligible; care advertised in all 50 states

Where it loses points

  • Terms, Privacy Policy and HIPAA notice are dead links - no legal entity, refund policy or governing law disclosed
  • Pharmacy partners not named - only 'US-licensed compounding pharmacies'
  • Homepage advertises GLP-1s 'from $149/mo' but the catalog lists $199/mo
  • On-site '4.9/5, 2,400+ reviews' is self-reported, not an independently verified rating

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard